Copyright
©2014 Baishideng Publishing Group Inc.
World J Methodol. Sep 26, 2014; 4(3): 163-188
Published online Sep 26, 2014. doi: 10.5662/wjm.v4.i3.163
Published online Sep 26, 2014. doi: 10.5662/wjm.v4.i3.163
Table 2 The largest health care companies in the world based on annual revenues
Rank | Company | Country | Total annual revenue(USD billions) |
1 | Johnson and Johnson | United States | 61.90 |
2 | Pfizer | United States | 50.01 |
3 | Roche | Switzerland | 47.35 |
4 | GlaxoSmithKline | United Kingdom | 45.83 |
5 | Novartis | Switzerland | 44.27 |
6 | Sanofi | France | 41.99 |
7 | Astra Zeneca | United Kingdom/Sweden | 32.81 |
8 | Abbott Laboratories | United States | 30.76 |
9 | Merck and Co. | United States | 27.43 |
10 | Bayer HealthCare | Germany | 22.30 |
11 | Eli Lilly | United States | 21.84 |
12 | Bristol-Myers Squibb | United States | 18.81 |
- Citation: Kontoghiorghe CN, Andreou N, Constantinou K, Kontoghiorghes GJ. World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients. World J Methodol 2014; 4(3): 163-188
- URL: https://www.wjgnet.com/2222-0682/full/v4/i3/163.htm
- DOI: https://dx.doi.org/10.5662/wjm.v4.i3.163